Discovery of the decade? Injection 'could cure Alzheimer's in minutes'

  • Context: Medical 
  • Thread starter Thread starter SF
  • Start date Start date
  • Tags Tags
    Discovery Injection
Click For Summary

Discussion Overview

The discussion revolves around a claim regarding a treatment for Alzheimer's disease using etanercept, which reportedly leads to rapid cognitive improvements in patients. Participants explore the validity of these claims, the underlying mechanisms of the treatment, and the quality of the studies supporting it.

Discussion Character

  • Debate/contested
  • Exploratory
  • Technical explanation

Main Points Raised

  • Some participants express skepticism about the rapid improvements reported, suggesting that the study may have been poorly controlled and questioning the accuracy of patient diagnoses.
  • Others highlight the role of TNF-alpha as a versatile molecule involved in various biological processes, including synaptic plasticity and inflammation.
  • A participant references an editorial that discusses improvements over a longer treatment period, contrasting with the immediate effects claimed in promotional materials.
  • There are mentions of the lack of large-scale studies to validate the treatment's efficacy, with some participants pointing to the need for more rigorous scientific investigation.
  • One participant humorously suggests an alternative "cure" for Alzheimer's, reflecting a critical view of the claims being discussed.

Areas of Agreement / Disagreement

Participants do not reach a consensus; there are multiple competing views regarding the validity of the treatment claims, the quality of the studies, and the implications of TNF-alpha inhibition.

Contextual Notes

Limitations include potential biases in the reported studies, the need for accurate patient diagnoses, and the absence of large-scale clinical trials to substantiate the claims made about the treatment.

SF
Real or what?
http://www.belfasttelegraph.co.uk/health/article3603996.ece?a=3603996

They claim 90 per cent respond to the treatment, usually within minutes, and have released videos of patients to prove it.


In one, a nurse sits down with an 82-year-old patient, Marvin Millar, who frowns and mumbles incoherently as she asks him identify everyday objects such as a bracelet and a pencil, which he is unable to do.


But five minutes after being injected with etanercept – according to the film which was supplied and edited by the clinic – he greets his wife. Visibly shocked, she says he has not recognised her for years. Mr Miller then hugs her.


In a separate interview, also supplied by the clinic, she describes his improvements four weeks later, saying he makes sense 90 per cent of the time now, compared with none of the time before treatment started.
 
Last edited by a moderator:
Biology news on Phys.org
I was sure I had a discussion on this already, but can't find any prior threads on it. Maybe it was someplace else. What I recall was digging up the original article and not being particular impressed by the so-called "improvement" in a poorly controlled study. Or maybe there were some issues as to whether the patients were correctly diagnosed with Alzheimer disease. I need to dig around more to remember where I've read this and commented on it before so I don't do all that a second time.

Edit: Here's an older editorial on it. It certainly isn't talking about improvements as rapid as 5 min, which sounds completely unrealistic, but more over the course of a month of treatment.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1785212
 
Last edited:
Moonbear said:
I was sure I had a discussion on this already, but can't find any prior threads on it. Maybe it was someplace else. What I recall was digging up the original article and not being particular impressed by the so-called "improvement" in a poorly controlled study. Or maybe there were some issues as to whether the patients were correctly diagnosed with Alzheimer disease. I need to dig around more to remember where I've read this and commented on it before so I don't do all that a second time.

Edit: Here's an older editorial on it. It certainly isn't talking about improvements as rapid as 5 min, which sounds completely unrealistic, but more over the course of a month of treatment.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1785212


Here's a page seems to give the treatment details and rationale behind them. This is from the Institute for Neurological Research itself... (a private medical group).

The Tobinick Method™ for treatment of Alzheimer's Disease at the INR®: outline of the scientific rationale

http://www.nrimed.com/physician.html
 
Last edited by a moderator:
It's interesting that it's supposedly a TNF-alpha inhibitor. TNF-alpha seems to be a very versatile molecule, I'm hearing about it being implicated in everything from synaptic plasticity to inflammation, and growth control / apoptosis.
 
Cincinnatus said:
It's interesting that it's supposedly a TNF-alpha inhibitor. TNF-alpha seems to be a very versatile molecule, I'm hearing about it being implicated in everything from synaptic plasticity to inflammation, and growth control / apoptosis.

Where are you hearing this?
 
Where are you hearing this

There are hundreds if not thousands of articles about TNF-alpha. Try searching on pubmed, it's all there.
 
In Britain we can already cure Alzheimers by simply releasing the vicim from prison - within a few weeks they are fully recovered and able to run internaioanl companies.
 
Cincinnatus said:
There are hundreds if not thousands of articles about TNF-alpha. Try searching on pubmed, it's all there.


Thank you. Here's another promo/report about this from medscape.com They pretty well say that there have been no large studies done with this therapy, yet.

Anti-TNF-alpha Therapy Produces Rapid Improvement in Alzheimer's Disease

Caroline Cassels

January 15, 2008 — Perispinal etanercept (Enbrel, Amgen), an anticytokine therapy that targets excess tumor necrosis factor–alpha (TNF-α) in the brain, has been shown to produce almost immediate cognitive and behavioral improvement in a patient with moderate Alzheimer's disease (AD).

If confirmed in larger studies, researchers say these findings may herald a major breakthrough in the treatment of the condition, which currently affects about 5 million Americans and 27 million individuals worldwide.

Etanercept®, which was approved for human use in 1998 for the initial indication of rheumatoid arthritis, is currently used to treat a wide variety of inflammatory disorders in which TNF-α is thought to play a role.

http://www.medscape.com/viewarticle/568812